S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.00 (+0.16%)
AAPL   173.97 (-0.33%)
MSFT   289.78 (-0.53%)
META   174.50 (-0.20%)
GOOGL   120.04 (+0.41%)
AMZN   142.23 (+0.09%)
TSLA   908.07 (-0.43%)
NVDA   187.54 (+2.29%)
NIO   19.92 (-0.80%)
BABA   90.61 (+0.94%)
AMD   100.36 (+2.13%)
MU   62.93 (+2.13%)
T   18.41 (-0.05%)
CGC   3.81 (-6.16%)
F   16.13 (+0.62%)
GE   79.42 (-0.63%)
DIS   122.51 (-0.24%)
AMC   19.33 (-9.50%)
PYPL   99.73 (+0.31%)
PFE   48.54 (-1.48%)
NFLX   245.00 (+1.60%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.00 (+0.16%)
AAPL   173.97 (-0.33%)
MSFT   289.78 (-0.53%)
META   174.50 (-0.20%)
GOOGL   120.04 (+0.41%)
AMZN   142.23 (+0.09%)
TSLA   908.07 (-0.43%)
NVDA   187.54 (+2.29%)
NIO   19.92 (-0.80%)
BABA   90.61 (+0.94%)
AMD   100.36 (+2.13%)
MU   62.93 (+2.13%)
T   18.41 (-0.05%)
CGC   3.81 (-6.16%)
F   16.13 (+0.62%)
GE   79.42 (-0.63%)
DIS   122.51 (-0.24%)
AMC   19.33 (-9.50%)
PYPL   99.73 (+0.31%)
PFE   48.54 (-1.48%)
NFLX   245.00 (+1.60%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.00 (+0.16%)
AAPL   173.97 (-0.33%)
MSFT   289.78 (-0.53%)
META   174.50 (-0.20%)
GOOGL   120.04 (+0.41%)
AMZN   142.23 (+0.09%)
TSLA   908.07 (-0.43%)
NVDA   187.54 (+2.29%)
NIO   19.92 (-0.80%)
BABA   90.61 (+0.94%)
AMD   100.36 (+2.13%)
MU   62.93 (+2.13%)
T   18.41 (-0.05%)
CGC   3.81 (-6.16%)
F   16.13 (+0.62%)
GE   79.42 (-0.63%)
DIS   122.51 (-0.24%)
AMC   19.33 (-9.50%)
PYPL   99.73 (+0.31%)
PFE   48.54 (-1.48%)
NFLX   245.00 (+1.60%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.00 (+0.16%)
AAPL   173.97 (-0.33%)
MSFT   289.78 (-0.53%)
META   174.50 (-0.20%)
GOOGL   120.04 (+0.41%)
AMZN   142.23 (+0.09%)
TSLA   908.07 (-0.43%)
NVDA   187.54 (+2.29%)
NIO   19.92 (-0.80%)
BABA   90.61 (+0.94%)
AMD   100.36 (+2.13%)
MU   62.93 (+2.13%)
T   18.41 (-0.05%)
CGC   3.81 (-6.16%)
F   16.13 (+0.62%)
GE   79.42 (-0.63%)
DIS   122.51 (-0.24%)
AMC   19.33 (-9.50%)
PYPL   99.73 (+0.31%)
PFE   48.54 (-1.48%)
NFLX   245.00 (+1.60%)
NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$0.55
+0.02 (+3.08%)
(As of 08/18/2022 03:59 PM ET)
Add
Compare
Today's Range
$0.53
$0.55
50-Day Range
$0.42
$0.61
52-Week Range
$0.40
$2.51
Volume
200 shs
Average Volume
29,755 shs
Market Capitalization
$62.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NantHealth MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.70mentions of NantHealth in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.37) to ($0.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

957th out of 1,119 stocks

Data Processing & Preparation Industry

66th out of 76 stocks

NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Analyst Ratings Changes

Separately, StockNews.com began coverage on NantHealth in a report on Wednesday. They issued a "hold" rating for the company.

NantHealth Stock Down 4.6 %

NASDAQ:NH opened at $0.53 on Thursday. NantHealth has a twelve month low of $0.40 and a twelve month high of $2.51. The business has a 50-day moving average price of $0.51 and a 200-day moving average price of $0.66.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

NantHealth (NASDAQ:NH) Now Covered by Analysts at StockNews.com
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript
NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com
NantHealth, Inc. Common Stock (NH)
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/04/2021
Today
8/18/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

Net Income
$-58,260,000.00
Pretax Margin
-88.50%

Debt

Sales & Book Value

Annual Sales
$62.65 million
Book Value
($1.63) per share

Miscellaneous

Free Float
45,296,000
Market Cap
$62.99 million
Optionable
Optionable
Beta
1.82














NH Stock - Frequently Asked Questions

Should I buy or sell NantHealth stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NH shares.
View NH analyst ratings
or view top-rated stocks.

How have NH shares performed in 2022?

NantHealth's stock was trading at $1.0550 at the beginning of 2022. Since then, NH stock has decreased by 49.9% and is now trading at $0.5288.
View the best growth stocks for 2022 here
.

When is NantHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our NH earnings forecast
.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) released its earnings results on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company had revenue of $14.36 million for the quarter, compared to analyst estimates of $17.70 million. During the same period last year, the firm posted ($0.08) earnings per share.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Atria Wealth Solutions Inc. (0.43%), Millennium Management LLC (0.23%), State Street Corp (0.11%), Northern Trust Corp (0.08%), Hartline Investment Corp (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends
.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $0.53.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $61.10 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($0.48) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.